Loss of normal Alzheimer's disease-associated Presenilin 2 function alters antiseizure medicine potency and tolerability in the 6-Hz focal seizure model
IntroductionPatients with early-onset Alzheimer's disease (EOAD) experience seizures and subclinical epileptiform activity, which may accelerate cognitive and functional decline. Antiseizure medicines (ASMs) may be a tractable disease-modifying strategy; numerous ASMs are marketed with well-establis...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2023-08-01
|
| Reeks: | Frontiers in Neurology |
| Onderwerpen: | |
| Online toegang: | https://www.frontiersin.org/articles/10.3389/fneur.2023.1223472/full |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|